TFPI levels in control subjects
. | OC users, n = 54 . | OC nonusers, n = 99 . | Postmenopausal women, n = 90 . | Men, n = 201 . | All, n = 473 . |
|---|---|---|---|---|---|
| TFPI-free antigen, ng/mL | 6.17 (5.6-6.7) | 11.0 (10.2-11.9) | 14.5 (13.7-15.3) | 15.0 (14.4-15.6) | 12.7 (12.3-13.2) |
| TFPI total antigen, ng/mL | 50.1 (47.4-52.9) | 63.2 (60.7-65.6) | 74.5 (71.6-77.4) | 73.7 (71.7-75.7) | 68.1 (66.7-69.5) |
| TFPI activity, % | 93 (90-97) | 114 (112-117) | 123 (120-126) | 124 (122-126) | 118 (116-119) |
. | OC users, n = 54 . | OC nonusers, n = 99 . | Postmenopausal women, n = 90 . | Men, n = 201 . | All, n = 473 . |
|---|---|---|---|---|---|
| TFPI-free antigen, ng/mL | 6.17 (5.6-6.7) | 11.0 (10.2-11.9) | 14.5 (13.7-15.3) | 15.0 (14.4-15.6) | 12.7 (12.3-13.2) |
| TFPI total antigen, ng/mL | 50.1 (47.4-52.9) | 63.2 (60.7-65.6) | 74.5 (71.6-77.4) | 73.7 (71.7-75.7) | 68.1 (66.7-69.5) |
| TFPI activity, % | 93 (90-97) | 114 (112-117) | 123 (120-126) | 124 (122-126) | 118 (116-119) |
Entries are mean TFPI levels; parenthetical entries are 95% CIs.